Balchem Corporation
BCPC
$169.03
-$1.34-0.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.04B | 1.01B | 985.93M | 964.54M | 953.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.04B | 1.01B | 985.93M | 964.54M | 953.68M |
| Cost of Revenue | 666.53M | 650.48M | 632.95M | 621.68M | 617.48M |
| Gross Profit | 370.63M | 363.07M | 352.98M | 342.86M | 336.21M |
| SG&A Expenses | 142.31M | 140.13M | 136.28M | 132.25M | 135.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 827.35M | 808.58M | 787.03M | 771.29M | 769.81M |
| Operating Income | 209.82M | 204.97M | 198.90M | 193.26M | 183.87M |
| Income Before Tax | 199.03M | 193.48M | 185.33M | 177.54M | 166.45M |
| Income Tax Expenses | 44.19M | 44.28M | 42.58M | 41.00M | 37.98M |
| Earnings from Continuing Operations | 154.85 | 149.20 | 142.75 | 136.54 | 128.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 154.85M | 149.20M | 142.75M | 136.54M | 128.48M |
| EBIT | 209.82M | 204.97M | 198.90M | 193.26M | 183.87M |
| EBITDA | 255.22M | 249.55M | 242.90M | 238.29M | 231.56M |
| EPS Basic | 4.80 | 4.61 | 4.40 | 4.21 | 3.97 |
| Normalized Basic EPS | 3.87 | 3.74 | 3.59 | 3.44 | 3.23 |
| EPS Diluted | 4.75 | 4.57 | 4.36 | 4.17 | 3.93 |
| Normalized Diluted EPS | 3.83 | 3.71 | 3.56 | 3.41 | 3.20 |
| Average Basic Shares Outstanding | 97.06M | 129.61M | 129.72M | 129.67M | 129.48M |
| Average Diluted Shares Outstanding | 130.68M | 130.63M | 130.82M | 130.79M | 130.61M |
| Dividend Per Share | 0.96 | 0.87 | 0.87 | 0.87 | 0.87 |
| Payout Ratio | 18.27% | 18.95% | 19.81% | 20.71% | 19.91% |